Medical Devices
The role of the modern hospital CFO has changed considerably in recent years. Not only do they perform a vital strategic role overseeing enterprise planning and performance, by necessity they have become more involved in the clinical aspects of healthcare.
The U.S. Department of Health and Human Services will sponsor the advanced development of a next-generation portable ventilator to help fill the need for portable, low-cost, user-friendly and flexible ventilators in a pandemic or other public health emergency.
Putting technology in the hands of doctors that can provide real-time data can help cut costs, but such technology can be expensive for health systems. The question then becomes is it worth it economically?
There have been many ideas proposed as solutions for reducing costly hospital readmissions, but one concept that hasn't gotten much attention over the years is patient empowerment.
The market will continue to grow, but slowly, while international demand looks promising.
The U.S. Food and Drug Administration (FDA) announced Monday that it is part of the first public-private partnership to promote medical device regulatory science. The partnership will focus on speeding up the review and approval processes of new medical devices.
Healthcare reform is fundamentally changing the way hospitals are run. A combination of crushing costs, government edicts and fierce competition for the millions of newly insured patients that will result from federal healthcare legislation is putting the patient front and center.
The U.S. Department of Health and Human Services (HHS) will need to place a lot of emphasis on implementing the Affordable Care Act (ACA) in the coming year, according to the Office of Inspector General's (OIG) annual summary of management and performance challenges facing the agency, released this week.
Venture capital (VC) funding in the life sciences sector, which includes the biotechnology and medical device industries, decreased 39 percent in dollars and 22 percent in number of deals in Q2 2012 compared with Q2 2011, according to PricewaterhouseCoopers' recent MoneyTree report. Many industry analysts think this downward trend is likely to continue.
In a report released Thursday, the FDA outlined a four-step plan to better monitor and report on the effectiveness and safety of medical devices.